HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$17.19
Day range
$16.67 - $17.56
Year range
$3.35 - $17.56
Market cap
911.58M USD
Avg Volume
748.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 4.22M | -18.17% |
Operating expense | 32.59M | 9.20% |
Net income | -26.37M | -16.98% |
Net profit margin | -625.57 | -42.95% |
Earnings per share | -0.57 | -7.55% |
EBITDA | -27.81M | -15.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 178.58M | -29.60% |
Total assets | 205.18M | -27.19% |
Total liabilities | 64.84M | -4.61% |
Total equity | 140.34M | — |
Shares outstanding | 52.12M | — |
Price to book | 5.69 | — |
Return on assets | -32.72% | — |
Return on capital | -45.31% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -26.37M | -16.98% |
Cash from operations | -24.57M | -15.03% |
Cash from investing | 9.99M | -81.18% |
Cash from financing | 1.72M | -96.19% |
Net change in cash | -12.86M | -116.75% |
Free cash flow | -7.80M | 29.23% |
About
Founded
2014
Headquarters
Website
Employees
110